Literature DB >> 8904887

Proliferation of precursor B-lineage acute lymphoblastic leukaemia by activating the CD40 antigen.

E V Planken1, N H Dijkstra, M Bakkus, R Willemze, J C Kluin-Nelemans.   

Abstract

No reliable culture system exists for B-lineage acute lymphoblastic leukaemia (ALL). Recently we found that many different mature B-cell malignancies proliferate upon stimulation via the CD40 antigen, and this led us to investigate whether a similar CD40 activation on ALL cells could also induce proliferation. First, we measured CD40 expression in 21 ALL cases; all were CD40+, although mostly weak. Next, we triggered the CD40 antigen by anti-CD40 antibodies and by a CD40 ligand-expressing cell line. In addition, we measured the influence of IL-3, IL-4 and IL-7 with and without these stimuli. In 8/10 cases proliferation, measured by 3H-thymidine incorporation, could be induced after CD40 crosslinking, especially in the presence of IL-3. Stimulation via the CD40 ligand was more successful than using crosslinked anti-CD40 antibodies. IL-4 inhibited the spontaneous proliferation found in three cases, but stimulated proliferation after CD40 crosslinking. IL-7 did not contribute to proliferation. Morphology, immunophenotyping and surface marker analysis, combined with DNA flow cytometry confirmed that the proliferation found could be ascribed to the ALL cells. In conclusion, B-lineage ALL cases are CD40+, and many can be cultured using CD40 stimulation and IL-3.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8904887     DOI: 10.1046/j.1365-2141.1996.d01-1908.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  4 in total

1.  To respond or not to respond to CD40 agonism: That is the prediction.

Authors:  Xiaoyan Shi; David Dornan
Journal:  Oncoimmunology       Date:  2012-01-01       Impact factor: 8.110

2.  The oncogenic membrane protein LMP1 sequesters TRAF3 in B-cell lymphoma cells to produce functional TRAF3 deficiency.

Authors:  Pradeep Bangalore-Prakash; Laura L Stunz; Nurbek Mambetsariev; Amy L Whillock; Bruce S Hostager; Gail A Bishop
Journal:  Blood Adv       Date:  2017-12-18

Review 3.  Pediatric precursor B acute lymphoblastic leukemia: are T helper cells the missing link in the infectious etiology theory?

Authors:  Simone Bürgler; David Nadal
Journal:  Mol Cell Pediatr       Date:  2017-05-16

Review 4.  Characteristics and clinical trial results of agonistic anti-CD40 antibodies in the treatment of malignancies.

Authors:  Da-Ke Li; Wen Wang
Journal:  Oncol Lett       Date:  2020-08-31       Impact factor: 2.967

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.